NSTG.Q Stock Overview Develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. More details
Risk Analysis + 2 more risks
See All Risk Checks Capture your thoughts, links and company narrative
NS Wind Down Co., Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for NS Wind Down Historical stock prices Current Share Price US$0.072 52 Week High US$5.18 52 Week Low US$0.04 Beta 0.21 1 Month Change -28.24% 3 Month Change 2.52% 1 Year Change -98.22% 3 Year Change -99.89% 5 Year Change -99.76% Change since IPO -99.11%
Recent News & Updates
NS Wind Down Co. Files Form 15 Jun 27
NS Wind Down Co., Inc. Emerged from Bankruptcy Jun 26 First Amended Disclosure Statement Approved for NanoString Technologies, Inc. May 24
NanoString Technologies, Inc. announced delayed 10-Q filing May 12
Bruker Corporation (NasdaqGS:BRKR) completed the acquisition of Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q), NanoString Technologies Germany GmbH, Nanostring Technologies International, Inc. and NanoString Technologies Netherlands B.V. May 07 Bruker Corporation (NasdaqGS:BRKR) entered into an agreement to acquire Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q), NanoString Technologies Germany GmbH, Nanostring Technologies International, Inc. and NanoString Technologies Netherlands B.V. for approximately $390 million. See more updates
NS Wind Down Co. Files Form 15 Jun 27
NS Wind Down Co., Inc. Emerged from Bankruptcy Jun 26 First Amended Disclosure Statement Approved for NanoString Technologies, Inc. May 24
NanoString Technologies, Inc. announced delayed 10-Q filing May 12
Bruker Corporation (NasdaqGS:BRKR) completed the acquisition of Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q), NanoString Technologies Germany GmbH, Nanostring Technologies International, Inc. and NanoString Technologies Netherlands B.V. May 07 Bruker Corporation (NasdaqGS:BRKR) entered into an agreement to acquire Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q), NanoString Technologies Germany GmbH, Nanostring Technologies International, Inc. and NanoString Technologies Netherlands B.V. for approximately $390 million. The Nasdaq Stock Market to Delist the Common Stock of Nanostring Technologies Apr 10
NanoString Technologies, Inc. announced delayed annual 10-K filing Mar 17 NanoString Technologies, Inc. announced delayed annual 10-K filing Mar 16
Patient Square Capital, LP agreed to acquire Substantially all assets of global business operations from NanoString Technologies, Inc. (OTCPK:NSTG.Q) for approximately $220 million. Mar 11
NanoString Technologies, Inc.(NasdaqGM:NSTG) dropped from NASDAQ Composite Index Feb 14 NanoString Technologies, Inc.(NasdaqGM:NSTG) dropped from S&P Global BMI Index Motion for Joint Administration Approved for NanoString Technologies, Inc. Feb 07
Motion for Joint Administration Filed by NanoString Technologies, Inc. Feb 06
NanoString Technologies, Inc. Filed for Bankruptcy Feb 05
Nanostring Launches the CosMx 6,000 Plex RNA Assay and Showcases Whole Transcriptome Imaging Capability Feb 01
NanoString Technologies, Inc. Releases the First Public Dataset of the Whole Transcriptome Obtained At True Single-Cell Resolution on the CosMx Spatial Molecular Imager Jan 08
NanoString Technologies Receives Non-Compliance Notice from Nasdaq Jan 06
NanoString Technologies Receives Non-Compliance Notice from Nasdaq Jan 05
Investors Give NanoString Technologies, Inc. (NASDAQ:NSTG) Shares A 58% Hiding Dec 19
10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies Nov 18
NanoString Technologies, Inc. Updates Earnings Guidance for the Year 2023 Nov 08
Third quarter 2023 earnings: EPS misses analyst expectations Nov 07
Price target decreased by 8.2% to US$9.64 Oct 26
Price target decreased by 12% to US$9.64 Oct 24 NanoString Technologies, Inc. to Report Q3, 2023 Results on Nov 06, 2023
NanoString Technologies, Inc. Launches the Most Comprehensive Spatial Proteomics Panel Ever Offered Sep 14
Nanostring Appoints Todd Garland as Chief Commercial Officer Aug 29
New major risk - Share price stability Aug 09
Price target decreased by 22% to US$12.86 Aug 06
New major risk - Negative shareholders equity Aug 04
Second quarter 2023 earnings: EPS misses analyst expectations Aug 04
NanoString Technologies, Inc. Reiterates Earnings Guidance for the Full Year 2023 Aug 04 Delaware District Court Permits NanoString Technologies, Inc.'s Counterclaims That 10x Genomics and Harvard Violated the Antitrust Laws
NanoString Technologies, Inc. to Report Q2, 2023 Results on Aug 03, 2023 Jul 11
10X Genomics, Inc. Files New Patent Litigation Against Nanostring Technologies, Inc. and Vizgen, Inc. in the European Unified Patent Court Jun 02
Independent Director recently bought US$202k worth of stock May 28
Take Care Before Jumping Onto NanoString Technologies, Inc. (NASDAQ:NSTG) Even Though It's 42% Cheaper May 19
10X Genomics Wins Permanent Injunction Against Nanostring's CosMX Products May 18
First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind May 05
NanoString Technologies, Inc. Updates Earnings Guidance for the Year 2023 May 05
Independent Director exercised options to buy US$86k worth of stock. Apr 30
NanoString Technologies (NASDAQ:NSTG) Is Making Moderate Use Of Debt Apr 14
CEO, President & Director exercised options and sold US$203k worth of stock Mar 15
Independent Director recently bought US$123k worth of stock Mar 09
Consensus EPS estimates fall by 17% Mar 07
Full year 2022 earnings: EPS misses analyst expectations Mar 01
NanoString Technologies, Inc. to Report Q4, 2022 Results on Feb 28, 2023 Feb 15
NanoString Technologies, Inc. Showcases Ultra High-Plex 6K RNA Single Cell Imaging at the 2023 Advances in Genome Biology and Technology Feb 07
CEO, President & Director exercised options and sold US$60k worth of stock Jan 31
NanoString Releases Single Cell Spatial Transcriptomics Dataset Highlighting Data Quality of CosMx Spatial Molecular Imager Jan 20
NanoString Technologies, Inc. Provides Product and Service Revenue Guidance for the Fourth Quarter and Full Year 2022 Jan 09
CEO, President & Director recently bought US$499k worth of stock Dec 15
NanoString Technologies, Inc Begins Commercial Shipments of CosMx Spatial Molecular Imager and AtoMx Spatial Informatics Platform Dec 07
Price target decreased to US$17.00 Nov 16
Third quarter 2022 earnings: EPS and revenues miss analyst expectations Nov 08
Is It Too Late To Consider Buying NanoString Technologies, Inc. (NASDAQ:NSTG)? Oct 27
NanoString Technologies, Inc. to Report Q3, 2022 Results on Nov 07, 2022 Oct 13
NanoString, Visiopharm team up to develop workflows for spatial biology solutions Oct 13
NanoString Technologies (NASDAQ:NSTG) Has Debt But No Earnings; Should You Worry? Oct 05
An Intrinsic Calculation For NanoString Technologies, Inc. (NASDAQ:NSTG) Suggests It's 35% Undervalued Aug 08
Nanostring Technologies, Inc. Provides Revenue Guidance for 2022 Aug 06
Second quarter 2022 earnings: EPS misses analyst expectations Aug 05
Price target decreased to US$32.67 Aug 01
Now 23% undervalued after recent price drop Jul 14
NanoString Technologies, Inc. to Report Q2, 2022 Results on Aug 04, 2022 Jul 12
When Should You Buy NanoString Technologies, Inc. (NASDAQ:NSTG)? Jun 27
NanoString Unveils AtoMx Spatial Informatics Portal at the 2022 Advances in Genome Biology and Technology (AGBT) General Meeting Jun 07
Nanostring Technologies, Inc. Announces Plans to Commercially Unveil the Cosmx™ Spatial Molecular Imager Jun 03
NanoString Technologies, Inc. Launches Integrated Informatics to Facilitate Spatial Biology Research Using Next Generation Sequencing May 24
Consensus EPS estimates fall by 16% May 17 Shareholder Returns NSTG.Q US Life Sciences US Market 7D -10.3% 4.1% 0.7% 1Y -98.2% -0.9% 23.0%
See full shareholder returns
Return vs Market: NSTG.Q underperformed the US Market which returned 24.2% over the past year.
Price Volatility Is NSTG.Q's price volatile compared to industry and market? NSTG.Q volatility NSTG.Q Average Weekly Movement 47.9% Life Sciences Industry Average Movement 9.5% Market Average Movement 6.4% 10% most volatile stocks in US Market 18.9% 10% least volatile stocks in US Market 3.1%
Stable Share Price: NSTG.Q's share price has been volatile over the past 3 months.
Volatility Over Time: NSTG.Q's weekly volatility (48%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company NS Wind Down Co., Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files.
Show more NS Wind Down Co., Inc. Fundamentals Summary How do NS Wind Down's earnings and revenue compare to its market cap? NSTG.Q fundamental statistics Market cap US$3.47m Earnings (TTM ) -US$166.43m Revenue (TTM ) US$162.47m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) NSTG.Q income statement (TTM ) Revenue US$162.47m Cost of Revenue US$104.44m Gross Profit US$58.04m Other Expenses US$224.47m Earnings -US$166.43m
Last Reported Earnings
Sep 30, 2023
Earnings per share (EPS) -3.46 Gross Margin 35.72% Net Profit Margin -102.44% Debt/Equity Ratio -450.4%
How did NSTG.Q perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/06/25 06:46 End of Day Share Price 2024/06/25 00:00 Earnings 2023/09/30 Annual Earnings 2022/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources NS Wind Down Co., Inc. is covered by 10 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Catherine Ramsey Schulte Baird Dane Leone BTIG Kyle Mikson Canaccord Genuity
Show 7 more analysts 
